financetom
Business
financetom
/
Business
/
Tata Sons shortlists an expat CEO for Air India, members for new board: Report
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tata Sons shortlists an expat CEO for Air India, members for new board: Report
Dec 3, 2021 9:05 AM

Ahead of its official takeover in January 2022, Tata Sons has shortlisted an expat CEO to lead Air India. The company has also shortlisted members for reconstituting the board of the airline, according to an Economic Times report.

Share Market Live

NSE

However, a formal announcement is expected in January 2022, the report said.

While the new Air India CEO will finalise the management team for the national carrier, the members of the Air India board will have officials from Tata Sons, group aviation experts, and a retired government official as an independent director.

A marketing and branding plan for Air India is also being put together. Besides, discussions are also ongoing on ways to tackle employee unions.

Meanwhile, Talace Limited, which houses Air India and Air Asia, is chalking out a financial plan for working capital requirements like payment of salaries, refurbishing aircraft, and quality control expenses, among others. Tata Sons chairman N Chandrasekaran is likely to be the head of the Talace group and Bhaskar Bhat, Air Asia CEO, is expected to be a member of the group. Officials close to the government will also be part of the group.

In another significant development, the Tata group is also in the process of acquiring a stake in Kerala’s Cochin airport, the third largest airport in India in terms of international passenger traffic connecting India to West Asian countries. With this, the Tata Group would become the only company to have an operational stake in a major Indian airport, according to a Business Standard report. Currently, Air India has a 3 percent stake in Cochin International Airport.

In October, the Centre had signed a share purchase agreement with Tata Sons for the sale of Air India for Rs 18,000 crore.

(Edited by : Anshul)

First Published:Dec 3, 2021 6:05 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
3D Systems Receives EU Certification for 3D-Printed Dentures
3D Systems Receives EU Certification for 3D-Printed Dentures
Mar 25, 2026
08:44 AM EDT, 03/25/2026 (MT Newswires) -- 3D Systems ( DDD ) said Wednesday that it has received full-scope certification under the European Union Medical Device Regulation covering the quality system, technical documentation, and clinical evidence for its dental product portfolio. The company said that with the certification, it remains on schedule to launch its 3D-printed NextDent Jetted Dentures in...
Micron Technology Launches Cash Tender Offers for Outstanding Senior Notes
Micron Technology Launches Cash Tender Offers for Outstanding Senior Notes
Mar 25, 2026
08:45 AM EDT, 03/25/2026 (MT Newswires) -- Micron Technology ( MU ) said Wednesday it has commenced offers to purchase for cash six series of outstanding senior notes, with maturities ranging from 2031 to 2035. The securities include 5.300% senior notes due 2031 worth $1 billion, 5.650% senior notes due 2032 worth $500 million, 5.875% senior notes due 2033 worth...
Ibotta Partners With Uber to Bring Digital Promotions to Consumers
Ibotta Partners With Uber to Bring Digital Promotions to Consumers
Mar 25, 2026
08:43 AM EDT, 03/25/2026 (MT Newswires) -- Ibotta ( IBTA ) said Wednesday it is partnering with Uber Technologies ( UBER ) to bring digital promotions to Uber's ( UBER ) US grocery and retail services. Financial terms were not disclosed. The partnership gives brands access to shoppers at the point of purchase, the company said. Uber ( UBER )...
Update: Biogen Signs Licensing Deal With Alteogen Worth Up to $579 Million
Update: Biogen Signs Licensing Deal With Alteogen Worth Up to $579 Million
Mar 25, 2026
08:43 AM EDT, 03/25/2026 (MT Newswires) -- (Updates with confirmation from Alteogen) Biogen (BIIB) has entered an exclusive licensing agreement with Alteogen to develop subcutaneous formulations of two biologic therapies using Alteogen's ALT-B4 drug-delivery technology, the latter said Wednesday. Alteogen said it will receive an upfront payment of $20 million upon signing, with an additional $10 million payment once development...
Copyright 2023-2026 - www.financetom.com All Rights Reserved